Evaluation of viabet capsule, a herbal formulation, as an adjuvant treatment for diabetes mellitus type 2

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191015045124N1

Enrollment

Registered

2020-02-17

Start date

2020-01-07

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Diabetes mellitus due to underlying condition

Interventions

Intervention 1: Intervention group: viabet 500 mg three times a day for 3 months. Intervention 2: Control group: viabet placebo three times a day for 3 months.

Eligibility

Sex/Gender

All

Age

40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetes according to the 2019 ADA Guideline Only take metformin tablets BMI between 25 - 32

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Sensitivity to drug Taking other diabetes medications except metformin taking drugs that affect blood sugar such as glucocorticoids Other serious illnesses such as heart failure Stomach or duodenal ulcer Use of anticoagulants such as heparin

Design outcomes

Primary

Measure	Time frame
Fasting blood sugar. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: Measurement of serum level in the laboratory.;Hemoglobin A1C. Timepoint: Starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.	—

Secondary

Measure	Time frame
Serum creatinine. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Blood Urea Nitrogen. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Aspartate aminotransferase. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Alanine aminotransferase. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Triglyceride. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Cholesterol. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Low-density lipoprotein. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;High-density lipoprotein. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Weight. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: by scale.;Blood pressure. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: By manometer.	—

Measure

Time frame

Serum creatinine. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Blood Urea Nitrogen. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Aspartate aminotransferase. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Alanine aminotransferase. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Triglyceride. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Cholesterol. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Low-density lipoprotein. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;High-density lipoprotein. Timepoint: starting Study; End of study. Method of measurement: Measurement of serum level in the laboratory.;Weight. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: by scale.;Blood pressure. Timepoint: Starting Study; One month later; Two months later; End of study. Method of measurement: By manometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmid Tanzifi Roodi

Mashhad University of Medical Sciences

tasnifio9331@mums.ac.ir+98 51 3180 1588

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026